Product Code: ETC6188929 | Publication Date: Sep 2024 | Updated Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Shubham Deep | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The positron emission tomography (PET) market in Australia is expanding due to increasing demand for advanced diagnostic imaging solutions in oncology, cardiology, and neurology. PET scans provide detailed metabolic and functional imaging, improving disease detection and treatment planning.
The positron emission tomography (PET) market in Australia is growing due to increasing demand for accurate and non-invasive imaging solutions in oncology, cardiology, and neurology. PET scans provide detailed information on tissue and organ function, aiding in early diagnosis and treatment planning. Rising cases of cancer, growing elderly population, and increasing government investment in healthcare infrastructure are key market drivers. Technological advancements in PET imaging, including hybrid PET/CT and PET/MRI systems, are enhancing market growth.
The PET market in Australia is constrained by high production costs due to advanced imaging components and radioactive tracers. Regulatory requirements for radiopharmaceutical production and patient safety increase production complexity. Competition from MRI and CT scan systems reduces market demand. Limited access to PET scanners in rural areas further restricts market expansion.
The PET market in Australia is growing due to increasing demand for early-stage cancer diagnosis and neurological imaging. Investment opportunities exist in developing high-resolution, low-radiation PET systems with shorter scan times and AI-driven image analysis. Expanding access to PET imaging in regional and rural healthcare settings presents additional growth opportunities.
Positron emission tomography (PET) systems are regulated by the TGA under the Medical Device Guidelines. The government supports the development and importation of PET systems through the Medicare Benefits Schedule (MBS), which covers the costs of PET scans for diagnosing cancer, neurological disorders, and cardiac issues. Funding is also provided for research and development of PET imaging technology through the Medical Research Future Fund (MRFF).
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Positron Emission Tomography (PET) Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Positron Emission Tomography (PET) Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Positron Emission Tomography (PET) Market - Industry Life Cycle |
3.4 Australia Positron Emission Tomography (PET) Market - Porter's Five Forces |
3.5 Australia Positron Emission Tomography (PET) Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Australia Positron Emission Tomography (PET) Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Australia Positron Emission Tomography (PET) Market Revenues & Volume Share, By End-User, 2021 & 2031F |
4 Australia Positron Emission Tomography (PET) Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Australia Positron Emission Tomography (PET) Market Trends |
6 Australia Positron Emission Tomography (PET) Market, By Types |
6.1 Australia Positron Emission Tomography (PET) Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Australia Positron Emission Tomography (PET) Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 Australia Positron Emission Tomography (PET) Market Revenues & Volume, By Full Ring PET Scanners, 2021- 2031F |
6.1.4 Australia Positron Emission Tomography (PET) Market Revenues & Volume, By Partial Ring PET Scanners, 2021- 2031F |
6.2 Australia Positron Emission Tomography (PET) Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Australia Positron Emission Tomography (PET) Market Revenues & Volume, By Cardiology, 2021- 2031F |
6.2.3 Australia Positron Emission Tomography (PET) Market Revenues & Volume, By Neurology, 2021- 2031F |
6.2.4 Australia Positron Emission Tomography (PET) Market Revenues & Volume, By Oncology, 2021- 2031F |
6.2.5 Australia Positron Emission Tomography (PET) Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Australia Positron Emission Tomography (PET) Market, By End-User |
6.3.1 Overview and Analysis |
6.3.2 Australia Positron Emission Tomography (PET) Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 Australia Positron Emission Tomography (PET) Market Revenues & Volume, By Diagnostic Centers, 2021- 2031F |
6.3.4 Australia Positron Emission Tomography (PET) Market Revenues & Volume, By Others, 2021- 2031F |
7 Australia Positron Emission Tomography (PET) Market Import-Export Trade Statistics |
7.1 Australia Positron Emission Tomography (PET) Market Export to Major Countries |
7.2 Australia Positron Emission Tomography (PET) Market Imports from Major Countries |
8 Australia Positron Emission Tomography (PET) Market Key Performance Indicators |
9 Australia Positron Emission Tomography (PET) Market - Opportunity Assessment |
9.1 Australia Positron Emission Tomography (PET) Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Australia Positron Emission Tomography (PET) Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Australia Positron Emission Tomography (PET) Market Opportunity Assessment, By End-User, 2021 & 2031F |
10 Australia Positron Emission Tomography (PET) Market - Competitive Landscape |
10.1 Australia Positron Emission Tomography (PET) Market Revenue Share, By Companies, 2024 |
10.2 Australia Positron Emission Tomography (PET) Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |